Foppiani Luca, Del Monte Patrizia, Sartini Giovanni, Arlandini Anselmo, Quilici Paolo, Bandelloni Roberto, Marugo Alessandro, Bernasconi Donatella
Division of Endocrinology, Galliera Hospital, Genova, Italy.
Endocr Pract. 2007 Mar-Apr;13(2):176-81. doi: 10.4158/EP.13.2.176.
To describe an unusual case of intrathyroidal parathyroid carcinoma (PC), which was retrospectively diagnosed in a woman who underwent surgical treatment of a recurrent nodular goiter.
We report the clinical and biologic features of an intrathyroidal PC, discuss the challenges with distinguishing PC from parathyroid adenoma, and review the related literature.
A 67-year-old woman sought medical attention for dysphagia attributable to the recurrence of a normal functioning multinodular goiter. Thyroid ultrasonography disclosed a 3-cm solid inferior nodule. Because she refused surgical treatment and a trial of levothyroxine was unsuccessful, periodic follow-up examinations were scheduled. At 1-year follow-up, hypercalcemia (12.1 to 12.6 mg/dL) and low phosphorus levels (2.0 to 2.3 mg/dL) were found, and parathyroid hormone (PTH) levels were profoundly increased (481 to 721 pg/mL). Neck ultrasonography showed a large hypoechogenic solid nodule, not clearly cleaved from the right thyroid lobe, which was possibly compatible with an enlarged parathyroid gland; however, a sestamibi scan was negative. During total thyroidectomy, intraoperative frozen sections of the intrathyroid nodule were compatible with nodular goiter with cellular pleomorphism. Final histologic examination showed cellular nests with nuclear pleomorphism and invasive behavior into the thyroid tissue and likely into the vessels, in conjunction with immunohistochemical negativity for thyroglobulin and strong positivity for PTH. These findings were highly suggestive of and supported the diagnosis of PC. Postoperatively, calcium levels normalized, and PTH values declined considerably but remained slightly increased. Vitamin D supplementation helped normalize the PTH levels. The patient has undergone follow-up for 5 years and has shown no morphologic or biochemical signs of tumor recurrence.
PC is a rare entity but should be suspected in patients with hypercalcemia, substantially increased PTH levels, and a neck mass. In such patients, techniques such as sestamibi scanning may fail to localize the neoplasm. Surgical treatment remains the preferred technique for an optimal outcome of the disease. Nevertheless, lifelong follow-up is necessary.
描述一例罕见的甲状腺内甲状旁腺癌(PC)病例,该病例是在一名接受复发性结节性甲状腺肿手术治疗的女性患者中进行回顾性诊断的。
我们报告了一例甲状腺内PC的临床和生物学特征,讨论了鉴别PC与甲状旁腺腺瘤的挑战,并回顾了相关文献。
一名67岁女性因正常功能的多结节性甲状腺肿复发导致吞咽困难前来就医。甲状腺超声检查发现一个3厘米的实性下极结节。由于她拒绝手术治疗且左甲状腺素试验未成功,因此安排了定期随访检查。在1年的随访中,发现高钙血症(12.1至12.6mg/dL)和低磷水平(2.0至2.3mg/dL),甲状旁腺激素(PTH)水平显著升高(481至721pg/mL)。颈部超声检查显示一个大的低回声实性结节,与右甲状腺叶分界不清,可能与甲状旁腺增大相符;然而,锝[99mTc]甲氧基异丁基异腈扫描结果为阴性。在全甲状腺切除术中,甲状腺内结节的术中冰冻切片与具有细胞多形性的结节性甲状腺肿相符。最终组织学检查显示细胞巢具有核多形性,并侵犯甲状腺组织且可能侵犯血管,同时甲状腺球蛋白免疫组化阴性而PTH强阳性。这些发现高度提示并支持PC的诊断。术后,血钙水平恢复正常,PTH值大幅下降但仍略有升高。补充维生素D有助于使PTH水平恢复正常。该患者已接受5年随访,未出现肿瘤复发的形态学或生化迹象。
PC是一种罕见疾病,但对于高钙血症、PTH水平大幅升高且有颈部肿块的患者应予以怀疑。在此类患者中,如锝[99mTc]甲氧基异丁基异腈扫描等技术可能无法定位肿瘤。手术治疗仍然是实现该疾病最佳治疗效果的首选技术。然而,终身随访是必要的。